X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (9) 9
male (9) 9
animals (8) 8
humans (8) 8
neurosciences (7) 7
female (5) 5
rats (5) 5
middle aged (4) 4
rats, wistar (4) 4
activation (3) 3
adult (3) 3
aged (3) 3
aged, 80 and over (3) 3
amusements (3) 3
apparatus for physical training, gymnastics, swimming,climbing, or fencing (3) 3
ball games (3) 3
endocrinology & metabolism (3) 3
games (3) 3
human necessities (3) 3
medical colleges (3) 3
mice (3) 3
oncology (3) 3
oxidative stress (3) 3
prognosis (3) 3
proteins (3) 3
research (3) 3
research article (3) 3
sports (3) 3
training equipment (3) 3
ampa (2) 2
antidepressants (2) 2
behavioral sciences (2) 2
beta-catenin (2) 2
carcinoma (2) 2
carcinoma, squamous cell - metabolism (2) 2
cell movement (2) 2
cellular and molecular neuroscience (2) 2
cerebrovascular circulation - drug effects (2) 2
chinese population (2) 2
cognition disorders - drug therapy (2) 2
cognition disorders - etiology (2) 2
dentistry (2) 2
dentistry, oral surgery & medicine (2) 2
dependent protein-kinase (2) 2
depression (2) 2
diabetes (2) 2
diabetes mellitus, experimental - drug therapy (2) 2
disease models, animal (2) 2
disease progression (2) 2
distolingual root (2) 2
electric communication technique (2) 2
electricity (2) 2
elevated plus-maze (2) 2
esophageal neoplasms - metabolism (2) 2
esophageal neoplasms - pathology (2) 2
esophageal squamous cell carcinoma (2) 2
genetic research (2) 2
glucagon-like peptide-1 (2) 2
health aspects (2) 2
hyperglycemia (2) 2
immunohistochemistry (2) 2
insulin (2) 2
ischemia (2) 2
kinases (2) 2
lymphatic metastasis (2) 2
mandible (2) 2
metabolism (2) 2
mice, scid (2) 2
mood disorders (2) 2
motility (2) 2
mtor (2) 2
nitric oxide synthase type iii - drug effects (2) 2
oxidative stress - drug effects (2) 2
pathway (2) 2
performing operations (2) 2
radix entomolaris (2) 2
respiratory system (2) 2
root (2) 2
sarcosine (2) 2
signaling pathway (2) 2
squamous-cell carcinoma (2) 2
studies (2) 2
thai (2) 2
transcription (2) 2
transporting (2) 2
treatment-resistant depression (2) 2
2-de (1) 1
3c-like protease (1) 1
abdominal vagus (1) 1
activated protein-kinase (1) 1
active power filter (1) 1
acyl coenzyme a - metabolism (1) 1
adolescent (1) 1
adult rats (1) 1
after-treatment of the shaped products, e.g. repairing (1) 1
aktives filter (1) 1
altitude sickness - drug therapy (1) 1
amino acids (1) 1
amp-activated protein kinases - metabolism (1) 1
ampa receptor (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


BMC Neuroscience, ISSN 1471-2202, 06/2016, Volume 17, Issue 1, p. 37
Background: Glucagon-like peptide 1 (GLP-1) analogs protect a variety of cell types against oxidative damage and vascular and neuronal injury via binding to... 
Oxidative stress | Pelvic nerve | Cerebral microcirculation | GLP-1 agonist | Middle cerebral artery occlusion | Voiding function | GLYCEMIC CONTROL | ACTIVATION | ISCHEMIA | BLOOD-BRAIN-BARRIER | NEUROSCIENCES | HYPERGLYCEMIA | GLUCAGON-LIKE PEPTIDE-1 | SIGNALING PATHWAY | NEURONAL NITRIC-OXIDE | RAT-BRAIN | PARKINSONS-DISEASE | Infarction, Middle Cerebral Artery - physiopathology | Diabetes Mellitus, Experimental - drug therapy | Cerebrovascular Circulation - physiology | Oxidative Stress - physiology | Urination Disorders - physiopathology | Male | Glucagon-Like Peptide-1 Receptor - metabolism | Infarction, Middle Cerebral Artery - complications | Liraglutide - pharmacology | Protective Agents - pharmacology | Cognition Disorders - etiology | Diabetes Mellitus, Experimental - complications | Infarction, Middle Cerebral Artery - drug therapy | Diabetes Mellitus, Experimental - physiopathology | Cognition Disorders - physiopathology | Cerebrovascular Circulation - drug effects | Urination Disorders - drug therapy | Cognition Disorders - drug therapy | Hypoglycemic Agents - pharmacology | Peptides - pharmacology | Animals | Movement Disorders - physiopathology | Movement Disorders - etiology | Urination Disorders - etiology | Mice | Venoms - pharmacology | Oxidative Stress - drug effects | Glucagon-Like Peptide-1 Receptor - agonists | Nootropic Agents - pharmacology | Movement Disorders - drug therapy | Prevention | Brain damage | Cognition | Research
Journal Article
Behavioural Brain Research, ISSN 0166-4328, 01/2017, Volume 316, pp. 1 - 10
Sarcosine, an -methyl- -aspartate receptor enhancer, can improve depression-like behavior in rodent models and depression in humans. We found that a single... 
mTOR | Depression | AMPA | Long-term treatment | Sarcosine | TREATMENT-RESISTANT DEPRESSION | NMDA RECEPTOR | DEPENDENT PROTEIN-KINASE | FORCED SWIM TEST | ASPARTATE RECEPTOR COMPLEX | AMPA RECEPTOR | ELEVATED PLUS-MAZE | NEUROSCIENCES | MTOR SIGNALING PATHWAY | BEHAVIORAL-RESPONSES | MOOD DISORDERS | BEHAVIORAL SCIENCES | Proteins | Medical colleges | Antidepressants | Depression, Mental
Journal Article
Journal of Cerebral Blood Flow & Metabolism, ISSN 0271-678X, 11/2015, Volume 35, Issue 11, pp. 1790 - 1803
Glucagon-like peptide-1 (GLP-1) receptor activation in the brain provides neuroprotection. Exendin-4 (Ex-4), a GLP-1 analog, has seen limited clinical usage... 
ischemia/reperfusion | exendin-4 PLGA microsphere | neuroinflammation | diabetes | OXIDATIVE STRESS | ACTIVATION | BRAIN-INJURY | DIABETIC-RATS | NEUROSCIENCES | INSULIN | GLUCAGON-LIKE PEPTIDE-1 | ENDOCRINOLOGY & METABOLISM | NITRIC-OXIDE | C-PEPTIDE | RECEPTOR AGONIST | HEMATOLOGY | ISCHEMIC-STROKE | Carotid Arteries - drug effects | Neuroprotective Agents - therapeutic use | Diabetes Mellitus, Experimental - drug therapy | Rats, Wistar | Peptides - pharmacokinetics | Carotid Stenosis - drug therapy | Reperfusion Injury - drug therapy | Male | Peptides - administration & dosage | Drug Carriers | Microcirculation | Microspheres | Neuroprotective Agents - pharmacokinetics | Cognition Disorders - etiology | Injections, Subcutaneous | Venoms - administration & dosage | Neuroprotective Agents - administration & dosage | Cognition Disorders - psychology | Cerebrovascular Circulation - drug effects | Lactic Acid | Oncogene Protein v-akt - drug effects | Polyglycolic Acid | Rats | Carotid Stenosis - physiopathology | Reperfusion Injury - psychology | Cognition Disorders - drug therapy | Magnetic Resonance Imaging | Animals | Signal Transduction - drug effects | Brain Ischemia - drug therapy | Brain Ischemia - psychology | Venoms - therapeutic use | Nitric Oxide Synthase Type III - drug effects | Peptides - therapeutic use | Venoms - pharmacokinetics | Original | reperfusion | ischemia
Journal Article
Journal Article
Renewable Energy, ISSN 0960-1481, 01/2016, Volume 85, pp. 524 - 533
This paper proposes a three-port single-phase three-wire (TPSPTW) power converter interface integrating an isolated current-fed full-bridge power converter... 
Active power filter | Fuel cell | Single-phase three-wire | DESIGN | ENERGY & FUELS | GENERATION SYSTEM | INVERTER | CAPABILITY | Electric current converters | Fuel cells | Batteries
Journal Article
Applied Physics Letters, ISSN 0003-6951, 04/2002, Volume 80, Issue 15, pp. 2782 - 2784
A dual doped structure was proposed for obtaining organic light-emitting devices with high-efficiency and full-spectrum white light emission. The device... 
ELECTROLUMINESCENT DEVICES | PHYSICS, APPLIED | DIODES
Journal Article
International Journal of Cancer, ISSN 0020-7136, 08/2014, Volume 135, Issue 3, pp. 563 - 573
The transcriptional network of the SRY (sex determining region Y)‐box 17 (SOX17) and the prognostic impact of SOX17 protein expression in human cancers remain... 
transcriptional network | esophageal squamous cell carcinoma | tumor suppressor | SOX17 | prognosis | Esophageal squamous cell carcinoma | Prognosis | Transcriptional network | Tumor suppressor | PROMOTER HYPERMETHYLATION | METHYLATION | CPG ISLAND | PROLIFERATION | BETA-CATENIN | BREAST-CANCER | GENE | ONCOLOGY | SRY-BOX | SQUAMOUS-CELL CARCINOMA | CATENIN SIGNALING PATHWAY | Cell Proliferation | Carcinoma, Squamous Cell - genetics | Carcinoma, Squamous Cell - metabolism | Humans | Lung Neoplasms - metabolism | Middle Aged | Male | Promoter Regions, Genetic - genetics | Immunoenzyme Techniques | Esophageal Neoplasms - pathology | Neoplasm Recurrence, Local - pathology | Lung Neoplasms - secondary | Esophageal Neoplasms - metabolism | Female | Gene Expression Regulation, Neoplastic - physiology | Lung Neoplasms - genetics | Neoplasm Recurrence, Local - metabolism | Survival Rate | Lymphatic Metastasis | Mice, SCID | Disease Progression | Fibronectins - metabolism | Transcription Factors - metabolism | Xenograft Model Antitumor Assays | Animals | Esophageal Neoplasms - genetics | Carcinoma, Squamous Cell - secondary | Neoplasm Recurrence, Local - genetics | Biomarkers, Tumor - genetics | Mice | Neoplasm Staging | SOXF Transcription Factors - genetics | Cell Movement | Fibronectins | Squamous cell carcinoma | Genetic research | Development and progression | Genetic aspects | Genetic transcription | Esophageal cancer | Proteins | Protein expression | Motility | Metastasis | Rodents
Journal Article
BMC Neuroscience, ISSN 1471-2202, 10/2015, Volume 16, Issue 1, p. 61
Journal Article
Journal Article
Lung Cancer, ISSN 0169-5002, 2008, Volume 65, Issue 3, pp. 371 - 376
Journal Article